about
TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activityAPH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexesPresenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in Mammalian brainDelayed leukoencephalopathy after carbon monoxide poisoning presenting as subacute dementia.Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura.[Malignant lymphoma presented as left trigeminal neuralgia].[Prion disease--the characteristics and diagnostic points in Japan].Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay.Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.Descriptive epidemiology of prion disease in Japan: 1999-2012.Quantifying prion disease penetrance using large population control cohortsGraft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional studyLocalization and trafficking of endogenous anterior pharynx-defective 1, a component of Alzheimer's disease related gamma-secretase.Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress.Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.Ambulatory Gait Behavior in Patients With Dementia: A Comparison With Parkinson's Disease.The presenilin proteins are components of multiple membrane-bound complexes that have different biological activities.Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction.Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.[Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions].Multicentre multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt-Jakob disease: a reliability and agreement studyInsight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.Prospective 10-year surveillance of human prion diseases in Japan.Visual reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments.Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.Tacrolimus monotherapy: a promising option for ocular myasthenia gravis.Depressive disorder may be associated with raphe nuclei lesions in patients with brainstem infarction.Serial magnetic resonance imaging changes in sporadic Creutzfeldt-Jakob disease with valine homozygosity at codon 129 of the prion protein gene.Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy.Transient abundance of presenilin 1 fragments/nicastrin complex associated with synaptogenesis during development in rat cerebellum.Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.[Review of basic knowledge, surveillance and infectious control of prion disease].[Rapid progressive HTLV-1-associated myelopathy with bronchoalveolar lesions and a long spinal cord lesion extending to almost the entire spinal cord].Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein geneHereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nervesBrainstem congestion due to carotid-cavernous fistula via a shunt from the external carotid artery
P50
Q24321405-FC72CA69-B56B-4470-8856-29F285963968Q28216835-D2CBDD25-6954-4EE8-9FBC-255DC460B52AQ28589919-F5D26C3D-67E4-4FFB-962D-FA6C0C3E9F56Q30834848-4141AC2B-F2D3-4A40-9BFC-7E28838716F0Q33206144-98783B16-3895-4042-BB87-5C268977A619Q33408248-EDC8CD27-CEEA-4EB8-B3A5-414DFEAF85B2Q33498030-79AFE643-AB4C-49EF-9B06-5C59FB0DE1E8Q33599902-8EBE0F0D-E603-4C2A-8A7E-7CA129D73845Q33629468-E3241A0E-4D8E-4537-BC2F-5DDFFF68EC6FQ34571438-75A1E755-8A79-43D4-B531-572ADBA0AA1CQ34652909-B2AE4D43-7553-415C-9CA3-1C27CAE37BBFQ34766034-D5F0106C-8401-458E-96CA-EBAD2D2B9619Q36639581-84F65449-F599-4A0D-90F1-3B26AF17F1B7Q37121569-2D750540-9FE9-4FBB-A05E-CDE96B22E7CFQ39673194-A0E959D8-CABB-42F7-A2C9-08E2BA722D79Q39738000-94AFB571-7C8E-4827-B10F-2A71A7D25E3CQ40389365-25AEBED9-FB3C-493A-B83E-4D3D168A3EF6Q40537463-7904500D-494D-4CC0-847B-CC168A2B1C12Q40559975-075384E7-5E4F-4525-AC4D-11E35E48BCABQ40662233-D21C1F98-929F-4851-8A93-ECF2F965E16CQ40701415-DDE7E401-3898-4FE1-8570-356EE5538486Q40723781-2335F344-F2DA-4EF2-A007-85FCC794396FQ40752703-6FAAC27A-8760-4202-AA3E-726761FDE02FQ42266211-B8027A26-3C2B-454D-A690-CAE27C4C8A9EQ42882583-19143552-BD8B-434E-88C5-427CEEEE2062Q43928650-9E87D15B-6A7B-4DB3-873C-CF6977CFD976Q45327925-4C681AC7-2DCE-4F49-A408-854E8463894DQ45353752-B172F2D4-1D97-4CC2-833D-3CD0342F601EQ45747372-7407C68E-3723-4727-BDC7-723B55FFB71BQ47780317-92F771AD-10EC-4FF9-AF11-416B98D5206EQ48632955-7DB9A3F7-47BE-4149-A524-077B91A87A8DQ48669896-503CF993-DA46-49FE-AF3E-19B0FE999D4BQ48690743-FADD20A7-14E2-49D0-8487-49D73F6413F5Q49573029-0CE9C962-FD62-4780-891D-B1773C035DA5Q52739813-06014D9F-2D60-491D-9181-889412D57CA7Q54510177-9D614FC9-7198-4B9B-B52E-1B16099B75ABQ55239265-CF65B2AA-00FD-4544-8C22-9C6EB2834779Q58612140-D7EC3EB3-AC8C-488D-8B5F-6E3FB104B7ECQ82259588-37DEBB5B-8B54-4360-9D5A-996990957790Q84183598-AB496F16-E641-457A-A826-4321E41B107F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nobuo Sanjo
@ast
Nobuo Sanjo
@en
Nobuo Sanjo
@es
Nobuo Sanjo
@nl
Nobuo Sanjo
@sl
type
label
Nobuo Sanjo
@ast
Nobuo Sanjo
@en
Nobuo Sanjo
@es
Nobuo Sanjo
@nl
Nobuo Sanjo
@sl
prefLabel
Nobuo Sanjo
@ast
Nobuo Sanjo
@en
Nobuo Sanjo
@es
Nobuo Sanjo
@nl
Nobuo Sanjo
@sl
P106
P1153
6602360705
P31
P496
0000-0002-1226-2425